Hear what our previous attendees have to say about the NASH Summit
"Very targeted meeting filled with KOLs and industry leaders in this exciting field. Meeting organized and run better than any other conference I have attended."
"Good representation of pharma, biotech, CRO and regulatory colleagues, which lead to stimulating conversations and presentations on: pathophysiology of NASH, potential targets, challenges involved in NASH clinical studies and developing regulatory and payer perspectives."
"The content of the conference was appropriately current, multidisciplinary, and relevant. Also I was struck with how everything ran like a well oiled machine. Never a glitch. This does not happen by accident. My hats off to HansonWade!"
"Very informative, well-balanced review of the latest NASH research progress in relevant drug candidates and diagnotics. Was very pleased with the highly-interactive Summit organization."